SOLACI Research Registries were presented at the SOLACI-SBHCI 2023 Congress

The area of records within SOLACI – SOLACI Research – continues to grow and share the results of its investigations with the entire Latin American interventional community.

In this case, a dedicated session was held during the SOLACI-SBHCI 2023 Congress to present the data from the SOLACI records and to discuss the challenges of carrying out reliable research initiatives that allow extracting valuable information to support therapeutic approaches that result in a better quality of life for patients in the region.

In the first presentation, Dr. Nicolás Zaderenko presented the results to date from the Latin American Coronary Bifurcation Registry, which already includes more than 1300 patients in 10 countries in Latin America.

LATAMBif-Registry

Next, Dr. Alexandre Schaan de Quadros (BRA) was invited to present the results of LATAM CTO, a registry that is not part of SOLACI Research but collects valuable data on chronic occlusions in our region.

Later on, Dr. Maximiliano Rossi (ARG) shared the results of the SOLACI Peripheral Registry and highlighted the value of this registry because it allows access to data from patients in the region for the first time. The registry, created in 2020, surveys the reality of patients with Lower Limb Angioplasty in the region and aims to understand their clinical and angiographic characteristics. In this regard, this initiative already includes more than 1200 patients enrolled in more than 9 Latin American countries.

Registro-LATAM-Peripheral

Continuing with the session, Dr. Henrique Ribeiro (BRA) presented the TAVI Guidelines developed in conjunction with the Inter-American Society of Cardiology (SIAC). In this regard, during the symposium, the importance of having the support of a clinical society regarding data reliability was emphasized.

Finally, Dr. Pablo Lamelas, Director of SOLACI Research, presented the brand new Left Main Revascularization Guidelines, also developed with SIAC.

LM-Revasc-SOLACI-SIAC-guideline-slides-SOLACI-Rio-2023

Towards the end of the session, Dr. Mangione, former President of SOLACI, congratulated the members of the SOLACI Peripheral Registry for all the work done and encouraged them to continue working to make these registries even larger.

If you wish to join the SOLACI Research records, please write to research@solaci.org.”


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Check out the best images of the El Salvador 2024 Sessions

Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...